| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/25/2008 | CN100396287C Formulation containing phosphate derivatives of electron transfer agents |
| 06/25/2008 | CN100396285C Inhalative solution formulation containing tiotropium salt |
| 06/25/2008 | CN100396284C Novel galneical form for oral administration with prolonged release of molsidomine |
| 06/25/2008 | CN100396282C Slow released doxazosin mesilate capsule and its preparation process |
| 06/25/2008 | CN100396281C Use of rotigotine for treating the restless leg syndrome |
| 06/25/2008 | CN100396278C Medicinal micro pill core and its preparing method |
| 06/25/2008 | CN100396277C Method for preparing a compound of interaction of active substances with a porous support using supercritical fluid |
| 06/25/2008 | CN100396276C Compositions containing organic compounds |
| 06/24/2008 | US7392141 Polypeptides; genetic engineering |
| 06/24/2008 | US7390885 Humanized collagen antibodies and related methods |
| 06/24/2008 | US7390882 Compositions and methods for the diagnosis and treatment of tumor |
| 06/24/2008 | US7390875 Method for binding, in solution, a peptide and a lipophilic vector and uses thereof |
| 06/24/2008 | US7390834 Increased or improved bioavailability of the active agents for oral, intracolonic, pulmonary, and other routes of administrations |
| 06/24/2008 | US7390793 Have fixed, preselected hydrodynamic diameters and are formed from basic or acidic amphiphilic compounds; compound E5564 and derivatives |
| 06/24/2008 | US7390787 Comprising 8 to 25 amino acids and containing the formula: RXZXXZXB wherein Z is proline or valine; X is a hydrophobic residue; and B is a basic amino acid. |
| 06/24/2008 | US7390784 Binary complexes formed have an enlarged target binding surface area and thus exhibit increased affinity, specificity or selectivity as compared to free drug forms |
| 06/24/2008 | US7390783 Charged phospholipid compositions and methods for their use |
| 06/24/2008 | US7390780 For transfecting nucleic acids in vivo or ex vivo; vesicle forming lipid and hydrophilic polymer; gene therapy |
| 06/24/2008 | US7390668 Halogenated xanthan compound |
| 06/24/2008 | US7390633 Methods for preparing low molecular weight heparin with modified heparinase III |
| 06/24/2008 | US7390629 Tumor-activated prodrug compounds and treatment |
| 06/24/2008 | US7390519 Probiotic Lactobacillus salivarius strains |
| 06/24/2008 | US7390510 Water soluble complex of hypericin and a polyvinylpyrrolidone; diagnosing and treating tumors |
| 06/24/2008 | US7390506 Substituted or unsubstituted 5-nitrothiazole covalently attached to a lipid selected from fatty acids or esters; oral administration; parasitic, bacterial, viral, or fungal infections; equine protozoal myeloencephalitis (EPM) or coccidiosis; drug delivery, nontoxic, bioavailability |
| 06/24/2008 | US7390502 Administering a mammalian host for treating a disease caused by proliferation of eukaryotic cells a formulation containing a complex of lipid and a drug 7-ethyl-10-hydroxycamptothecin |
| 06/24/2008 | US7390500 Transdermal therapeutic system (TTS) with fentanyl as a active ingredient |
| 06/24/2008 | US7390498 implanting matrix for bioactive material which is biocompatible porous forms of beta -tricalcium phosphate granules support the development of new bone throughout its structural form, together with bone morphogenic protein as bioactive material |
| 06/24/2008 | US7390488 Administering platelet binding agent; complexing; activation of complex; thrombosis |
| 06/24/2008 | US7390411 Method for preparing a compound of interaction of active substances with a porous support using supercritical fluid |
| 06/21/2008 | WO2007068311A1 Oral delivery of protein drug using microemulsion |
| 06/21/2008 | CA2672707A1 Oral delivery of protein drug using microemulsion |
| 06/19/2008 | WO2008074032A1 Factor viia- (poly) sialic acid conjugate having prolonged in vivo half-life |
| 06/19/2008 | WO2008073856A2 Delivery of nanoparticles and/or agents to cells |
| 06/19/2008 | WO2008073851A2 Remotely triggered release from heatable surfaces |
| 06/19/2008 | WO2008073684A1 Composition for treating aging skin comprising a hydroxycinnamic acid such as p-coumaric acid |
| 06/19/2008 | WO2008073558A2 Water-dispersible oral, parenteral, and topical formulations for poorly water soluble drugs using smart polymeric nanoparticles |
| 06/19/2008 | WO2008073368A1 Peptide-based hair protectants |
| 06/19/2008 | WO2008073294A2 Inhibition of angiogenesis and tumor growth by inhibitors of beta ii or delta protein kinase c |
| 06/19/2008 | WO2008072836A1 Inclusion complex comprising clopidogrel |
| 06/19/2008 | WO2008072584A1 Liposome encapsulating ammine-platinum complex at high concentration, and method for production of the liposome |
| 06/19/2008 | WO2008072535A1 Pharmaceutical composition containing low-substituted hydroxypropylcellulose |
| 06/19/2008 | WO2008072534A1 Solid medicinal preparation containing mannitol or lactose |
| 06/19/2008 | WO2008072532A1 Pharmaceutical composition having improved storage stability |
| 06/19/2008 | WO2008072379A1 Method for producing modified biopolymer and method for crosslinking biopolymers |
| 06/19/2008 | WO2008072230A1 Novel injectable chitosan mixtures forming hydrogels |
| 06/19/2008 | WO2008071851A1 Polyvalent bioconjugates |
| 06/19/2008 | WO2008071594A2 Polypeptides with the capacity to entrap drugs |
| 06/19/2008 | WO2008071394A1 Abeta antibody parenteral formulation |
| 06/19/2008 | WO2008071009A1 Novel ligand guided block copolymers for targeted drug delivery |
| 06/19/2008 | WO2008070996A1 Medical implants with a combination of compounds |
| 06/19/2008 | WO2008070961A1 Linker-based lecithin microemulsion delivery vehicles |
| 06/19/2008 | WO2008070950A1 Pharmaceutical solution formulations for encapsulation into gelatin capsules or other dosage forms |
| 06/19/2008 | WO2008070902A1 Tgf-beta compositions for treating infertility |
| 06/19/2008 | WO2008051383A3 Use of alcohol co-solvents to improve pegylation reaction yields |
| 06/19/2008 | WO2008050341A3 Novel psychotropic agents having glutamate nmda activity |
| 06/19/2008 | WO2008049042A3 Ophthalmic compositions containing diglycine |
| 06/19/2008 | WO2008046606A3 Topical composition for the treatment of eczema |
| 06/19/2008 | WO2008045563A3 Modification of ionic strength in antibody-solutions to reduce opalescence/aggregates |
| 06/19/2008 | WO2008043777B1 Use of monoclonal antibodies specific to the o-acetylated form of gd2 ganglioside for the treatment of certain cancers |
| 06/19/2008 | WO2008039052A3 Process for stabilizing famotidine |
| 06/19/2008 | WO2008017828A3 Antibodies specific for human cd98 heavy antigen |
| 06/19/2008 | WO2008005705A3 Metal-containing formulations and methods of use |
| 06/19/2008 | WO2007139815A3 Imaging and therapeutic method using progenitor cells |
| 06/19/2008 | WO2007019845A8 Method for encapsulating therapeutic substances in cells |
| 06/19/2008 | WO2007010032A3 Intermolecular association complex of a carrier, preferably an n-alkylamino -1-desoxylactitol and of an active ingredient |
| 06/19/2008 | US20080147178 Copolymer of methoxyethyl or ethoxyethyl (meth)acrylate and a (meth)acrylic acid ester, amide or thioester containing a zwitterionic group, such as choline, phosphoryl choline, phosphorylethanolamine, phosphatidylethanolamine, phosphatidylserine, or sulfobetaine; ductility and toughness; stent coating |
| 06/19/2008 | US20080147065 Flowable carrier compositions and methods of use |
| 06/19/2008 | US20080146784 Moncolonal antibody for use in diagnosis and treatment of cell proliferative disorders; immunotherapy; tissue engineering |
| 06/19/2008 | US20080146783 Loading solution onto a hydrophobic interaction chromatography matrix equilibrated in aqueous buffer at a salt concentration high enough to promote matrix-protein interactions, applying a gradient of decreasing salt concentration, and collecting the conjugate, leaving the unconjugated albumin |
| 06/19/2008 | US20080146781 Modified Human Four Helical Bundle Polypeptides and Their Uses |
| 06/19/2008 | US20080146771 Polymer-succinimide-linked active agent conjugate, |
| 06/19/2008 | US20080146678 O/W Emulsion Composition |
| 06/19/2008 | US20080146677 Application of the homeopathic ingredient to an element selected from second ingredient, an excipient, and a capsule assembly; and encapsulating the second ingredient in a closed capsule assembly, wherein the closed capsule assembly containing the homeopathic carrier |
| 06/19/2008 | US20080146652 Anhydrous formulations formed of diblock copolymer having hydrophilic block and hydrophobic block, an additive selected from a polymer and an organic solvent, the solvent being water-miscible and biocompatible, and a drug; provides for formation of micelles having enhanced ability to incorporate drugs |
| 06/19/2008 | US20080146651 Injectable Composition for the Treatment of Cancers |
| 06/19/2008 | US20080146598 Combinatorial drug therapy using polymer-drug conjugates |
| 06/19/2008 | US20080146581 Solubility of hydrophobic drugs with a compound having a carboxylic acid moiety |
| 06/19/2008 | US20080146530 Re-epithelializing pharmaceutical compositions comprising xanthan gum |
| 06/19/2008 | US20080146522 Inflammation, allergic diseases, metastatic cancers, pathogen infections; glycosaminoglycan related molecules |
| 06/19/2008 | US20080146490 Glp-1 Analogue Formulations |
| 06/19/2008 | US20080146488 strongly immunogenic polypeptide to a more weakly immunogenic polypeptide can precipitate and focus a CpG adjuvant to increase in vivo priming of a cytotoxic T-lymphocyte (CTL) response, and thus increase the immunogenicity of the more weakly immunogenic polypeptide |
| 06/19/2008 | US20080145938 Buffer solution for electroporation and a method comprising the use of the same |
| 06/19/2008 | US20080145456 Aethereum gerani, Aethereum rosmarini, Aethereum citri, Mentholum, and ethylene-diamine-tetra-acetic acid-alkali metal salt (EDTA); eliminating pain of different locomotor complaints of the body |
| 06/19/2008 | US20080145450 Delivery or removal of metals from biological systems |
| 06/19/2008 | US20080145441 Core of metal atoms of gold, silver or copper covalently linked to a carbohydrate group and to at least 20 ligands |
| 06/19/2008 | US20080145440 Cisplatin intercalated into the double-helical DNA; stably retains cisplatin and exhibits an excellent slow-release property |
| 06/19/2008 | US20080145436 Aqueous phase dispersed in an oily phase, a silicone emulsifier, a hydrophilic acrylic polymers and 2-acrylamido-2-methylpropanesulfonic acid polymers, and a silicon-based filler |
| 06/19/2008 | US20080145435 Composition Comprising a Volatile Solvent, an Organic Filler and a Mineral Filler, and Uses Thereof |
| 06/19/2008 | US20080145432 Amphiphilic polymer with an inner nucleus of hydrophilic segment of amphiphilic polymer, a hydrophobic outer layer of hydrophobic segment of amphiphilic polymer, and a surface modifier bonded to the hydrophobic outer layer |
| 06/19/2008 | US20080145419 High viscosity liquid controlled delivery system and medical or surgical device |
| 06/19/2008 | US20080145417 Pharmaceutical formulation for the efficient administration apomorphine, 6ar-(-)-n-propyl-norapomorphine and their derivatives and pro-drugs thereof |
| 06/19/2008 | US20080145414 Method of Producing Fine Particles Surface-Modified with Water-Soluble Substance |
| 06/19/2008 | US20080145409 Composition for the treatment and prevention of peptic ulcer |
| 06/19/2008 | US20080145401 use in sclerotherapy of blood vessels; injecting blood dispersible gases carbon dioxide and/or oxygen, and a sclerosing agent polidocanol; avoiding use of potentially hazardous amounts of nitrogen; treating varicose veins disorders; drug delivery method |
| 06/19/2008 | US20080145387 N-(3-aminopropyl)-N,N-dimethyl-2,3-bis(-9-tetradeceneyloxy)-1 -propanaminium salt; cytofectin and lipid mixture |
| 06/19/2008 | US20080145383 Method for Solubilizing Peptide Mixtures |
| 06/19/2008 | US20080145359 Imaging, diagnosis and treatment of disease |
| 06/19/2008 | US20080145354 Polyoxyethylene glycol; biocompatability; bioavailability |
| 06/19/2008 | US20080145343 Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof |
| 06/19/2008 | US20080145338 Acrylate-terminated poly(beta-amino esters); high throughput assay; biocompatability |